SCHOTT Pharma Investor Relations Material

SCHOTT Pharma AG & Co. KGaA specializes in developing, producing, and selling advanced drug containment and delivery solutions for the injectable drugs market. Catering to the pharmaceutical and biotechnology industries globally, the company offers a comprehensive portfolio that includes polymer and glass syringes, ampoules, vials, and cartridges. Notable products in its range include the syriQ series of glass and polymer syringes designed for various applications such as vaccines, biologics, aesthetic treatments, infusion therapy, and deep-cold applications, as well as the cartriQ and adaptiQ lines for cartridges and vials, respectively. It is headquartered in Mainz, Germany, and its shares are listed on the Frankfurt Stock Exchange.